Stage IIIA Melanoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB17475 | Incomplete Freund's adjuvant | 0 | Completed | 1 |
DB15081 | Melanoma antigen recognized by T-cells 1 | 0 | Completed | 1 |
DB06530 | Resiquimod | 0 | Completed | 1 |
DB05153 | Cabozantinib | 1 | Terminated | 1 |
DB08875 | Cabozantinib | 1 | Terminated | 1 |
DB05238 | Vemurafenib | 1 | Terminated | 1 |
DB08881 | Vemurafenib | 1 | Terminated | 1 |
DB15018 | Agatolimod | 2 | Completed | 1 |
DB00041 | Aldesleukin | 2 | Terminated | 1 |
DB06626 | Axitinib | 2 | Completed | 1 |
DB06626 | Axitinib | 2 | Terminated | 1 |
DB11967 | Binimetinib | 2 | Completed | 1 |
DB08912 | Dabrafenib | 2 | Terminated | 1 |
DB01254 | Dasatinib | 2 | Completed | 1 |
DB14800 | GP-100 antigen | 2 | Completed | 2 |
DB00619 | Imatinib | 2 | Completed | 1 |
DB17475 | Incomplete Freund's adjuvant | 2 | Completed | 2 |
DB06186 | Ipilimumab | 2 | Terminated | 1 |
DB00020 | Sargramostim | 2 | Completed | 1 |
DB11689 | Selumetinib | 2 | Terminated | 1 |
DB08911 | Trametinib | 2 | Terminated | 1 |
DB16626 | Tyrosinase | 2 | Completed | 2 |